Somers M, Peleman C, Van Malderen K, Verlinden W, Francque S, De Schepper H
Department of Gastroenterology and Hepatology, Antwerp University Hospital.
University of Antwerp.
Acta Gastroenterol Belg. 2017 Oct-Dec;80(4):463-469.
The treatment of fecal incontinence (FI) depends upon the dominant pathophysiology: impaired sphincter contractility or overflow due to pelvic floor dyssynergia and insufficient rectal emptying. In this study, we aimed to define the manometric and anorectal ultrasound characteristics in FI patients with and without constipation.
We did a retrospective study of 365 anal manometries, performed between October 2012 and July 2015, in patients with FI. Clinical information was obtained from questionnaires. In 220 of these patients an anorectal ultrasound was also available. Key results : A high prevalence of self-reported constipation was seen in the total population of FI patients (66%). This number was lower (31%) when Rome IV criteria were applied. A very high percentage of manometric pelvic floor dyssynergia was seen in the total population with FI (81%). However, patients with FI and constipation did not show pelvic floor dyssynergia more often than patients without constipation. Anal resting pressure, squeeze pressure and anorectal pressure sensitivity were not different when comparing patients without and with constipation. The prevalence of a functional defecation disorder (FDD) in our study population of FI patients was 20%. Wexner score in this subgroup was lower compared with patients without FDD. Anal sphincter defects were more prevalent in women than men, and were associated with diminished sphincter contractility.
A very high percentage of FI patients showed manometric pelvic floor dyssynergia. The coexistence of fecal incontinence and constipation did not increase this percentage.
Constipation is a frequent and underestimated cause of FI. A correct diagnosis has a major impact on treatment. We aimed to characterize the manometric and transrectal ultrasound profile of FI patients with and without signs of coexisting constipation. - A very high percentage of incontinent patients showed pelvic floor dyssynergia, however no significant difference between the group with and the group without constipation was seen. Anal resting pressure, squeeze pressure and anorectal pressure sensitivity did not differ significantly either.
大便失禁(FI)的治疗取决于主要的病理生理学机制:括约肌收缩功能受损或由于盆底协同失调和直肠排空不足导致的充溢性失禁。在本研究中,我们旨在明确有无便秘的FI患者的测压和肛肠超声特征。
我们对2012年10月至2015年7月期间对365例FI患者进行的肛门测压进行了回顾性研究。临床信息通过问卷获取。其中220例患者还进行了肛肠超声检查。主要结果:在FI患者总体中,自我报告的便秘患病率很高(66%)。应用罗马IV标准时,这一数字较低(31%)。在FI患者总体中,测压显示盆底协同失调的比例非常高(81%)。然而,有便秘的FI患者并不比无便秘的患者更常出现盆底协同失调。比较有无便秘的患者时,肛门静息压、挤压压和肛肠压力敏感性无差异。在我们的FI患者研究人群中,功能性排便障碍(FDD)的患病率为20%。该亚组的韦克斯纳评分低于无FDD的患者。肛门括约肌缺陷在女性中比男性更普遍,并且与括约肌收缩力减弱有关。
很高比例的FI患者显示测压盆底协同失调。大便失禁和便秘并存并未增加这一比例。
便秘是FI常见且被低估的原因。正确诊断对治疗有重大影响。我们旨在描述有无并存便秘迹象的FI患者的测压和经直肠超声特征。- 很高比例的失禁患者显示盆底协同失调,然而便秘组和无便秘组之间未见显著差异。肛门静息压、挤压压和肛肠压力敏感性也无显著差异。